摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6,7-dimethoxy-2,3-di-2-thiophenylquinoxaline | 861883-42-3

中文名称
——
中文别名
——
英文名称
6,7-dimethoxy-2,3-di-2-thiophenylquinoxaline
英文别名
6,7-Dimethoxy-2,3-di-thiophen-2-yl-quinoxaline;6,7-dimethoxy-2,3-dithiophen-2-ylquinoxaline
6,7-dimethoxy-2,3-di-2-thiophenylquinoxaline化学式
CAS
861883-42-3
化学式
C18H14N2O2S2
mdl
——
分子量
354.453
InChiKey
QECWNBHGOWRVDA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    24
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    101
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6,7-dimethoxy-2,3-di-2-thiophenylquinoxalinesodium hydroxide氢溴酸溶剂黄146 作用下, 以 二氯甲烷 为溶剂, 反应 3.0h, 生成 6,7-Di-thiophen-2-yl-[1,3]dioxolo[4,5-g]quinoxaline
    参考文献:
    名称:
    Synthesis of selective SRPK-1 inhibitors: Novel tricyclic quinoxaline derivatives
    摘要:
    SR protein-specific kinase-1 (SRPK-1) has been identified as a validated target for hepatitis B virus (HBV). A series of novel tricyclic quinoxaline derivatives was designed and synthesised as potential kinase inhibitory antiviral agents and was found to be active and selective for SRPK-1 kinase. Most of these novel compounds have drug-like properties according to experimentally determined Log P and Log S values. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.04.064
  • 作为产物:
    参考文献:
    名称:
    Synthesis of selective SRPK-1 inhibitors: Novel tricyclic quinoxaline derivatives
    摘要:
    SR protein-specific kinase-1 (SRPK-1) has been identified as a validated target for hepatitis B virus (HBV). A series of novel tricyclic quinoxaline derivatives was designed and synthesised as potential kinase inhibitory antiviral agents and was found to be active and selective for SRPK-1 kinase. Most of these novel compounds have drug-like properties according to experimentally determined Log P and Log S values. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.04.064
点击查看最新优质反应信息

文献信息

  • One-pot synthesis of quinoxalines from reductive coupling of 2-nitroanilines and 1,2-diketones using indium
    作者:Ahra Go、Geunsoo Lee、Jaeho Kim、Seolhee Bae、Byung Min Lee、Byeong Hyo Kim
    DOI:10.1016/j.tet.2015.01.007
    日期:2015.2
    reduction-cyclization of 2-nitroanilines and 1,2-diketones to give quinoxalines was investigated. Using indium and an appropriate acid such as acetic acid or indium(III) chloride, various quinoxaline derivatives including 2,3-dialkylquinoxalines, 2,3-diphenylquinoxalines, 2,3-di-2-thiophenylquinoxalines, 2,3-di(pyridin-2-yl)quinoxalines, and dibenzo[a,c]phenazines were synthesized in moderate to excellent
    研究了2-硝基苯胺和1,2-二酮的一锅还原环化反应生成喹喔啉。使用铟和适当的酸,例如乙酸或氯化铟(III),各种喹喔啉衍生物包括2,3-二烷基喹喔啉,2,3-二苯基喹喔啉,2,3-二-2-硫代苯基喹喔啉,2,3-二(吡啶) -2-基)喹喔啉和二苯并[ a,c ]吩嗪以中等至优异的产率合成。
  • Synthesis of selective SRPK-1 inhibitors: Novel tricyclic quinoxaline derivatives
    作者:Zsolt Székelyhidi、János Pató、Frigyes Wáczek、Péter Bánhegyi、Bálint Hegymegi-Barakonyi、Dániel Ero˝s、György Mészáros、Ferenc Hollósy、Doris Hafenbradl、Sabine Obert、Bert Klebl、György Kéri、László O˝rfi
    DOI:10.1016/j.bmcl.2005.04.064
    日期:2005.7
    SR protein-specific kinase-1 (SRPK-1) has been identified as a validated target for hepatitis B virus (HBV). A series of novel tricyclic quinoxaline derivatives was designed and synthesised as potential kinase inhibitory antiviral agents and was found to be active and selective for SRPK-1 kinase. Most of these novel compounds have drug-like properties according to experimentally determined Log P and Log S values. (c) 2005 Elsevier Ltd. All rights reserved.
查看更多